Cargando…

Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy

BACKGROUND: Excellent dosimetric characteristics were demonstrated for volumetric modulated arc therapy (VMAT) in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). In a single-center retrospective analysis, we tested whether these advantages may translate into significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dröge, Leif Hendrik, Weber, Hanne Elisabeth, Guhlich, Manuel, Leu, Martin, Conradi, Lena-Christin, Gaedcke, Jochen, Hennies, Steffen, Herrmann, Markus Karl, Rave-Fränk, Margret, Wolff, Hendrik Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617910/
https://www.ncbi.nlm.nih.gov/pubmed/26486986
http://dx.doi.org/10.1186/s12885-015-1812-x
_version_ 1782396861153280000
author Dröge, Leif Hendrik
Weber, Hanne Elisabeth
Guhlich, Manuel
Leu, Martin
Conradi, Lena-Christin
Gaedcke, Jochen
Hennies, Steffen
Herrmann, Markus Karl
Rave-Fränk, Margret
Wolff, Hendrik Andreas
author_facet Dröge, Leif Hendrik
Weber, Hanne Elisabeth
Guhlich, Manuel
Leu, Martin
Conradi, Lena-Christin
Gaedcke, Jochen
Hennies, Steffen
Herrmann, Markus Karl
Rave-Fränk, Margret
Wolff, Hendrik Andreas
author_sort Dröge, Leif Hendrik
collection PubMed
description BACKGROUND: Excellent dosimetric characteristics were demonstrated for volumetric modulated arc therapy (VMAT) in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). In a single-center retrospective analysis, we tested whether these advantages may translate into significant clinical benefits. We compared VMAT to conventional 3D conformal radiotherapy (3DCRT) in patients, homogeneously treated according to the control arm of the CAO/ARO/AIO-04 trial. METHODS: CRT consisted of pelvic irradiation with 50.4/1.8Gy by VMAT (n = 81) or 3DCRT (n = 107) and two cycles of 5-fluorouracil. Standardized total mesorectal excision surgery was performed within 4–6 weeks. The tumor regression grading (TRG) was assessed by the Dworak score. Acute and late toxicity were evaluated via the Common Terminology Criteria for Adverse Events and the Late effects of normal tissues scale, respectively. Side effects greater than or equal to grade 3 were considered high-grade. RESULTS: Median follow-up was 18.3 months in the VMAT group and 61.5 months in the 3DCRT group with no differences in TRG between them (p = 0.1727). VMAT treatment substantially reduced high-grade acute and late toxicity, with 5 % versus 20 % (p = 0.0081) and 6 % vs. 22 % (p = 0.0039), respectively. With regard to specific organs, differences were found in skin reaction (p = 0.019) and proctitis (p = 0.0153). CONCLUSIONS: VMAT treatment in preoperative CRT for LARC showed the potential to substantially reduce high-grade acute and late toxicity. Importantly, we could demonstrate that VMAT irradiation did not impair short-term oncological results. We conclude, that the reduced toxicity after VMAT irradiation may pave the way for more efficient systemic therapies, and hopefully improved patient survival in the multimodal treatment of LARC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1812-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4617910
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46179102015-10-25 Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy Dröge, Leif Hendrik Weber, Hanne Elisabeth Guhlich, Manuel Leu, Martin Conradi, Lena-Christin Gaedcke, Jochen Hennies, Steffen Herrmann, Markus Karl Rave-Fränk, Margret Wolff, Hendrik Andreas BMC Cancer Research Article BACKGROUND: Excellent dosimetric characteristics were demonstrated for volumetric modulated arc therapy (VMAT) in preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). In a single-center retrospective analysis, we tested whether these advantages may translate into significant clinical benefits. We compared VMAT to conventional 3D conformal radiotherapy (3DCRT) in patients, homogeneously treated according to the control arm of the CAO/ARO/AIO-04 trial. METHODS: CRT consisted of pelvic irradiation with 50.4/1.8Gy by VMAT (n = 81) or 3DCRT (n = 107) and two cycles of 5-fluorouracil. Standardized total mesorectal excision surgery was performed within 4–6 weeks. The tumor regression grading (TRG) was assessed by the Dworak score. Acute and late toxicity were evaluated via the Common Terminology Criteria for Adverse Events and the Late effects of normal tissues scale, respectively. Side effects greater than or equal to grade 3 were considered high-grade. RESULTS: Median follow-up was 18.3 months in the VMAT group and 61.5 months in the 3DCRT group with no differences in TRG between them (p = 0.1727). VMAT treatment substantially reduced high-grade acute and late toxicity, with 5 % versus 20 % (p = 0.0081) and 6 % vs. 22 % (p = 0.0039), respectively. With regard to specific organs, differences were found in skin reaction (p = 0.019) and proctitis (p = 0.0153). CONCLUSIONS: VMAT treatment in preoperative CRT for LARC showed the potential to substantially reduce high-grade acute and late toxicity. Importantly, we could demonstrate that VMAT irradiation did not impair short-term oncological results. We conclude, that the reduced toxicity after VMAT irradiation may pave the way for more efficient systemic therapies, and hopefully improved patient survival in the multimodal treatment of LARC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1812-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-20 /pmc/articles/PMC4617910/ /pubmed/26486986 http://dx.doi.org/10.1186/s12885-015-1812-x Text en © Dröge et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dröge, Leif Hendrik
Weber, Hanne Elisabeth
Guhlich, Manuel
Leu, Martin
Conradi, Lena-Christin
Gaedcke, Jochen
Hennies, Steffen
Herrmann, Markus Karl
Rave-Fränk, Margret
Wolff, Hendrik Andreas
Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
title Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
title_full Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
title_fullStr Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
title_full_unstemmed Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
title_short Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
title_sort reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3d conformal radiotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617910/
https://www.ncbi.nlm.nih.gov/pubmed/26486986
http://dx.doi.org/10.1186/s12885-015-1812-x
work_keys_str_mv AT drogeleifhendrik reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT weberhanneelisabeth reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT guhlichmanuel reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT leumartin reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT conradilenachristin reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT gaedckejochen reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT henniessteffen reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT herrmannmarkuskarl reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT ravefrankmargret reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy
AT wolffhendrikandreas reducedtoxicityinthetreatmentoflocallyadvancedrectalcanceracomparisonofvolumetricmodulatedarctherapyand3dconformalradiotherapy